13th annual report the preeminent source for medical benefit drug trend

publications Spring 2024 Prime Therapeutics Report March 15, 2024 The Prime Therapeutics Report is your source for innovative managed care strategies, trends and updates. Our cover story (Page 6)...

Managed Healthcare Executive

Biobetters are just a nickname; they’re based on existing biologics but with a few key differences

Perspectives High-Cost Therapy Profile: April Detailed information about prademagene zamikeracel Topical surgical application Date High Cost Therapy Profile Gene therapy/Dermatology Prademagene...

Get the most value and best outcomes from C&GT Cell and gene therapies (C&GTs) represent breakthrough science, but often come at a high cost. Breadcrumb Home Our solutions Condition management Cell...

Perspectives High-Cost Therapy Profile: May Detailed information about Fidanacogene elaparvovec-dzkt Intravenous (IV) High Cost Therapy Profile Gene therapy/Hematology Fidanacogene elaparvovec-dzkt...

Breadcrumb Home Newsroom Custom Content Publications Drug Approvals Monthly Update: September 2024 PUBLICATIONS Drug Approvals Monthly Update: September 2024 This monthly update of United States...

Designed for unions, delivered with care At Prime Therapeutics (Prime), we built our model around transparency, flexibility and aligned incentives from the start. We don’t just help unions respond...

Read Drug Approvals Monthly Update: June 2024 This monthly update of United States (U.S.) Food and Drug Administration (FDA) approvals provides a review of newly approved specialty drugs, new...

PUBLICATIONS FDA Decisions Expected Drug pipeline for January 2025 December 17, 2024 Your monthly synopsis of new drugs expected to hit the market At Prime Therapeutics (Prime), we have positioned...

publications High Cost Therapy Profile: November 2024 Zenocutuzumab Intravenous (IV) November 20, 2024 Oncology Proposed indications Pancreatic ductal adenocarcinoma (PDAC) and non–small...

Read Drug Approvals Monthly Update: April 2024 This monthly update of United States (U.S.) Food and Drug Administration (FDA) approvals provides a review of newly approved specialty drugs, new...

publications Trending Topics & Drug Approvals: July 2025 Your source for the latest drug information highlights July 30, 2025 Trending Topics Hot topics Elevidys update Sarepta has resumed...

PUBLICATIONS FDA Decisions Expected: September 2025 Your monthly synopsis of new drugs expected to hit the market August 14, 2025 Drug pipeline for September 2025 At Prime Therapeutics (Prime), we...

Drug Approvals Quarterly Update: July 2024 This wrap-up provides a review of newly approved drugs, recent drug launches, new indications and news of note on drugs in the approval process....

PUBLICATIONS FDA Decisions Expected: March 2025 Your monthly synopsis of new drugs expected to hit the market February 14, 2025 Drug pipeline for March 2025 At Prime Therapeutics (Prime), we have...

publications FDA Decisions Expected Drug pipeline for November 2024 October 14, 2024 Your monthly synopsis of new drugs expected to hit the market At Prime Therapeutics (Prime), we have...

PUBLICATIONS FDA Decisions Expected: November 2025 Your monthly synopsis of new drugs expected to hit the market October 13, 2025 Drug pipeline for November 2025 At Prime Therapeutics (Prime), we...

Read Drug Approvals Monthly Update: May 2024 This monthly update of United States (U.S.) Food and Drug Administration (FDA) approvals provides a review of newly approved specialty drugs, new...

PUBLICATIONS FDA Decisions Expected: June 2025 Your monthly synopsis of new drugs expected to hit the market May 21, 2025 Drug pipeline for June 2025 At Prime Therapeutics (Prime), we have...

For the first time, Prime Therapeutics hosted the AMCP Nexus specialty keynote, addressing trends in cell and gene therapy and rare disease and immunology categories

Read Drug Approvals Monthly Update: August 2024 This monthly update of United States (U.S.) Food and Drug Administration (FDA) approvals provides a review of newly approved specialty drugs, new...

Breadcrumb Home Newsroom Custom Content Publications FDA Decisions Expected: October 2024 PUBLICATIONS FDA Decisions Expected: October 2024 Your monthly synopsis of new drugs expected to hit the...

Perspectives High-Cost Therapy Profile: March Detailed information about Sotatercept Subcutaneous (SC) High Cost Therapy Profile Cardiovascular Sotatercept Subcutaneous (SC) Merck/Bristol-Myers...

Breadcrumb Home Read, watch, listen Read Explore what's trending at Prime Example Link Example Link Card Title example Example Link Example Link Card Title example The Latest Tab 1 Press Releases...

Drs. Tracey Garcia and Amy Pappas, board-certified neurologists, reviewed migraine risk factors and treatments in a recent webinar moderated by Dr. Marci Chodroff, vice president of medical affairs

PUBLICATIONS FDA Decisions Expected: December 2025 Your monthly synopsis of new drugs expected to hit the market November 18, 2025 Drug pipeline for December 2025 At Prime Therapeutics (Prime), we...

publications High Cost Therapy Profile: January 2025 Tabelecleucel Intravenous (IV) Oncology January 8, 2025 Proposed indications Epstein-Barr virus-positive (EBV+) post-transplant...

Managed Healthcare Executive

USA Today

Reuters

Insider

CNBC

Formulary Watch

Star Tribune

Business Insider

Endpoint News

Reuters

Reuters